Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Morishima

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Chemical & Pharmaceutical Bulletin|December 1, 1992
Renin inhibitors. II. Synthesis and structure-activity relationships of N-terminus modified inhibitors containing a homostatine analogueS Atsuumi, M Nakano, Y Koike, et al.
Journal of Radiation Research|January 6, 2001
Excess relative risk of solid cancer mortality after prolonged exposure to naturally occurring high background radiation in Yangjiang, ChinaQ Sun, S Akiba, Z Tao, et al.
Bioorganic & Medicinal Chemistry Letters|April 1, 2000
Synthesis and biological activities of NB-506 analogues modified at the glucose groupM Ohkubo, T Nishimura, H Kawamoto, et al.
Biochemical and Biophysical Research Communications|March 31, 1989
A novel nonpeptidic, orally active renin inhibitorH Morishima, Y Koike, M Nakano, et al.
Cancer Research|September 15, 1999
Mode of action of a new indolocarbazole anticancer agent, J-107088, targeting topoisomerase IT Yoshinari, M Ohkubo, K Fukasawa, et al.
Chemical & Pharmaceutical Bulletin|February 1, 1985
Synthetic studies on an antitumor antibiotic, bleomycin. XIV. The synthesis of Boc-pyrimidoblamic acidM Otsuka, M Narita, M Yoshida, et al.
The Journal of Antibiotics|August 1, 1985
Differanisole A, a new differentiation inducing substanceH Oka, K Asahi, H Morishima, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2000
Structure-activity relationships of trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems. Part 1: J-111,347 and related compoundsH Imamura, N Ohtake, A Shimizu, et al.
Carcinogenesis|September 2, 1999
CYP1A2 is not the primary enzyme responsible for 4-aminobiphenyl-induced hepatocarcinogenesis in miceS Kimura, M Kawabe, J M Ward, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 1999
Synthesis and biological activities of topoisomerase I inhibitors, 6-N-amino analogues of NB-506M Ohkubo, K Kojiri, H Kondo, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Chemical & Pharmaceutical Bulletin|December 1, 1992
Renin inhibitors. II. Synthesis and structure-activity relationships of N-terminus modified inhibitors containing a homostatine analogueS Atsuumi, M Nakano, Y Koike, et al.
Journal of Radiation Research|January 6, 2001
Excess relative risk of solid cancer mortality after prolonged exposure to naturally occurring high background radiation in Yangjiang, ChinaQ Sun, S Akiba, Z Tao, et al.
Bioorganic & Medicinal Chemistry Letters|April 1, 2000
Synthesis and biological activities of NB-506 analogues modified at the glucose groupM Ohkubo, T Nishimura, H Kawamoto, et al.
Biochemical and Biophysical Research Communications|March 31, 1989
A novel nonpeptidic, orally active renin inhibitorH Morishima, Y Koike, M Nakano, et al.
Cancer Research|September 15, 1999
Mode of action of a new indolocarbazole anticancer agent, J-107088, targeting topoisomerase IT Yoshinari, M Ohkubo, K Fukasawa, et al.
Chemical & Pharmaceutical Bulletin|February 1, 1985
Synthetic studies on an antitumor antibiotic, bleomycin. XIV. The synthesis of Boc-pyrimidoblamic acidM Otsuka, M Narita, M Yoshida, et al.
The Journal of Antibiotics|August 1, 1985
Differanisole A, a new differentiation inducing substanceH Oka, K Asahi, H Morishima, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2000
Structure-activity relationships of trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems. Part 1: J-111,347 and related compoundsH Imamura, N Ohtake, A Shimizu, et al.
Carcinogenesis|September 2, 1999
CYP1A2 is not the primary enzyme responsible for 4-aminobiphenyl-induced hepatocarcinogenesis in miceS Kimura, M Kawabe, J M Ward, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 1999
Synthesis and biological activities of topoisomerase I inhibitors, 6-N-amino analogues of NB-506M Ohkubo, K Kojiri, H Kondo, et al.
Pageof 10